DEKKERS MARIJN E 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Jun 13, 2022
Insider Transaction Report
Form 4
DEKKERS MARIJN E
Director
Transactions
- Award
Class A Common Stock
2022-06-10+70,921→ 2,192,587 total - Award
Stock Option
2022-06-10+108,516→ 108,516 totalExercise: $2.82Exp: 2032-06-10→ Class A Common Stock (108,516 underlying)
Holdings
- 5,780,364(indirect: By Novalis LifeSciences Investments I, L.P.)
Class A Common Stock
Footnotes (3)
- [F1]The vesting date of the restricted stock units and stock options, and in the case of the stock options, the exercise date, will be the earlier of either June 10, 2023 or the day immediately prior to the date of the next Annual Meeting of Shareholders of the Issuer occurring after the date of grant, in either case, subject to the Reporting Person continuing in service as a Non-Employee Director through such date.
- [F2]The reporting person is the manager of the general partner of Novalis LifeSciences Investments I, L.P. ("Novalis LifeSciences"), and as such, has sole voting and dispositive power over the shares held by Novalis LifeSciences and, as a result, may be deemed to share beneficial ownership of the shares held by Novalis LifeSciences.
- [F3]In accordance with the Non-Employee Director Compensation Policy of the Issuer, the Black-Scholes value of the option award as of the grant date is $200,000.